Dr. Pusztai on Challenges With Neoadjuvant HER2 Therapy
November 28th 2017Lajos Pusztai, MD, professor of medicine, chief of Breast Medical Oncology, Yale Cancer Center and Yale School of Medicine, discusses the challenges facing neoadjuvant treatment of patients with HER2-positive breast cancer
Read More